Zanganeh Mahkam 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-13 4:51 pm Purchase |
2023-03-08 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 36,882,393 5.270% |
31,399,111 (+572.63%) |
Filing |
| 2020-11-25 4:11 pm Purchase |
2020-11-22 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 5,483,282 6.580% |
3,323 (+0.06%) |
Filing |
| 2020-11-10 4:20 pm Purchase |
2020-11-06 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 5,479,959 6.580% |
149,701 (+2.81%) |
Filing |
| 2020-09-28 4:40 pm Purchase |
2020-09-18 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 5,330,258 7.800% |
5,330,258 (New Position) |
Filing |